BioCentury
ARTICLE | Finance

Ebb & Flow

January 5, 2009 8:00 AM UTC

Next to having cash in the bank, the next best thing is having a bankroll waiting on the shelf.

In the closing days of 2008, Array BioPharma, Ista and MediGene each made moves that promise access to capital to underpin their clinical development plans and strengthen negotiating positions with potential partners...